Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isa Mambetsariev

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Current Oncology (Toronto, Ont.)|October 28, 2025
Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase InhibitionAdam Rock, Isa Mambetsariev, Siddhika Pareek, et al.
Cold Spring Harbor Molecular Case Studies|May 9, 2023
Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinomaDiogo Garcia, Isa Mambetsariev, Jeremy Fricke, et al.
Journal of Clinical Medicine|March 11, 2023
A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision MedicineMartin Sattler, Isa Mambetsariev, Jeremy Fricke, et al.
Oncotarget|October 6, 2017
Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experienceYuan Yuan, Susan E Yost, John Yim, et al.
Oncotarget|January 7, 2017
Genomic mutation-driven metastatic breast cancer therapy: a single center experienceYuan Yuan, Susan E Yost, John Yim, et al.
Translational Lung Cancer Research|June 10, 2024
A novel <i>HLA-DQB2::MET</i> gene fusion variant in lung adenocarcinoma with prolonged response to tepotinib: a case reportDouglas Dias E Silva, Isa Mambetsariev, Jeremy Fricke, et al.
JCO Precision Oncology|December 12, 2024
Clinical Utility of a Circulating Tumor Cell-Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advanced Non-Small Cell Lung CancerJyoti Malhotra, Ramya Muddasani, Jeremy Fricke, et al.
Magnetic Resonance Imaging|March 18, 2020
Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastasesBihong T Chen, Taihao Jin, Ningrong Ye, et al.
Frontiers in Oncology|March 22, 2021
Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung CancerBihong T Chen, Taihao Jin, Ningrong Ye, et al.
Journal of Clinical Medicine|October 23, 2019
Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer CellsTamara Mirzapoiazova, Haiqing Li, Anusha Nathan, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Current Oncology (Toronto, Ont.)|October 28, 2025
Small Cell Transformation of EGFR-Mutant NSCLC Treated with Tyrosine Kinase InhibitionAdam Rock, Isa Mambetsariev, Siddhika Pareek, et al.
Cold Spring Harbor Molecular Case Studies|May 9, 2023
Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinomaDiogo Garcia, Isa Mambetsariev, Jeremy Fricke, et al.
Journal of Clinical Medicine|March 11, 2023
A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision MedicineMartin Sattler, Isa Mambetsariev, Jeremy Fricke, et al.
Oncotarget|October 6, 2017
Correction: Genomic mutation-driven metastatic breast cancer therapy: a single center experienceYuan Yuan, Susan E Yost, John Yim, et al.
Oncotarget|January 7, 2017
Genomic mutation-driven metastatic breast cancer therapy: a single center experienceYuan Yuan, Susan E Yost, John Yim, et al.
Translational Lung Cancer Research|June 10, 2024
A novel <i>HLA-DQB2::MET</i> gene fusion variant in lung adenocarcinoma with prolonged response to tepotinib: a case reportDouglas Dias E Silva, Isa Mambetsariev, Jeremy Fricke, et al.
JCO Precision Oncology|December 12, 2024
Clinical Utility of a Circulating Tumor Cell-Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advanced Non-Small Cell Lung CancerJyoti Malhotra, Ramya Muddasani, Jeremy Fricke, et al.
Magnetic Resonance Imaging|March 18, 2020
Radiomic prediction of mutation status based on MR imaging of lung cancer brain metastasesBihong T Chen, Taihao Jin, Ningrong Ye, et al.
Frontiers in Oncology|March 22, 2021
Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung CancerBihong T Chen, Taihao Jin, Ningrong Ye, et al.
Journal of Clinical Medicine|October 23, 2019
Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer CellsTamara Mirzapoiazova, Haiqing Li, Anusha Nathan, et al.
Pageof 8